Table 1.

Patient characteristics

	All Patients (n = 25)		Patients with Mutation Detected in ctDNA (n = 12)
	Number	%1	Number	%2	P-value
Mean age (+/− SD)	57.6 (+/− 16.3)	–	57.0 (+/− 13.7)	–	0.873
Sex
Male	18	72	8	44	0.673
Female	7	28	4	57
Disease state at blood draw
Active	22	88	12	55	0.220
NED/Inactive	3	12	0	0
Disease stage at blood draw
IIIa	1	4	0	0	0.480
IIIb	2	8	0	0
IIIc	1	4	1	100
IV	21	84	11	52
Received any prior therapy
Yes	21	84	11	52	0.593
No	4	16	1	25
Receiving therapy at time of blood draw
Yes	17	68	9	53	0.673
No	8	32	3	38
Total number of previous therapeutic regimens
0	4	16	1	25	0.304
1–2	14	56	6	43
≥ 3	7	28	5	71
Received chemotherapy prior to blood draw
Yes	2	8	2	100	0.220
No	23	92	10	44
Received TKI prior to blood draw
Yes	6	24	3	50	1.000
No	19	76	9	47
Received checkpoint inhibitor prior to blood draw
Yes	16	64	9	56	0.411
No	9	36	3	33
Received radiation prior to blood draw
Yes	10	40	7	70	0.111
No	15	60	5	33

¹The denominator for this % calculation is the n=25 total patients included in this table.

²The denominator for this % calculation varies row by row. It is the number of total patients shown in the left-most column for that row’s patient category.